Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
A cancer drug that targets a previously "undruggable" protein and nearly doubles the survival period of patients with metastatic pancreatic cancer has received approval from the U.S. Food and Drug Administration (FDA). This is the first targeted therapy to broadly block the "RAS" protein, which is m...
Kwak Soo-keun
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
A cancer drug that targets a previously "undruggable" protein and nearly doubles the survival period of patients with metastatic pancreatic cancer has received approval from the U.S. Food and Drug Administration (FDA). This is the first targeted therapy to broadly block the "RAS" protein, which is m...
Kwak Soo-keun
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Kwak Soo-keun
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
A cancer drug that targets a previously "undruggable" protein and nearly doubles the survival period of patients with metastatic pancreatic cancer has received approval from the U.S. Food and Drug Administration (FDA). This is the first targeted therapy to broadly block the "RAS" protein, which is m...
Kwak Soo-keun
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
A cancer drug that targets a previously "undruggable" protein and nearly doubles the survival period of patients with metastatic pancreatic cancer has received approval from the U.S. Food and Drug Administration (FDA). This is the first targeted therapy to broadly block the "RAS" protein, which is m...
Kwak Soo-keun
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Kwak Soo-keun
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
Nepal Flood Destroys 90% of Korea South-East Power Hydropower Facilities
A major flood in Nepal has caused extensive damage to the upper facilities and base camp of a hydropower plant construction site being built by Doosan...
Jun Joon-beom
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
A cancer drug that targets a previously "undruggable" protein and nearly doubles the survival period of patients with metastatic pancreatic cancer has received approval from the U.S. Food and Drug Administration (FDA). This is the first targeted therapy to broadly block the "RAS" protein, which is m...
Kwak Soo-keun
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
A cancer drug that targets a previously "undruggable" protein and nearly doubles the survival period of patients with metastatic pancreatic cancer has received approval from the U.S. Food and Drug Administration (FDA). This is the first targeted therapy to broadly block the "RAS" protein, which is m...
Kwak Soo-keun
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Industry
FDA Approves RAS-Targeting Drug That Doubles Pancreatic Cancer Survival
Kwak Soo-keun
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
Entertainment+
Rosé becomes first K-pop artist to win VMAs 'Song of the Year'
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
North Korea
Chung Dong-young's 100,000-Fold Nuclear Claim Sparks Controversy
Opinion
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
American Haenyeo
American Haenyeo
American Haenyeo
American Haenyeo
American Haenyeo
American Haenyeo
Opinion
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
Cape Verde's Sodade: A Lesson for Koreans
American Haenyeo
American Haenyeo
American Haenyeo
American Haenyeo
American Haenyeo
American Haenyeo
Entertainment+
Entertainment+
Entertainment+
Lifestyle
Lifestyle
Lifestyle
Most Read News
Most Read News
Most Read News